VAM
CERE

Vazirani Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Vazirani Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$1.02M – 40
2024
Q2 		$1.02M Buy
+25,000
New +$1.04M 2.18% 12

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Vazirani Asset Management's CERE Position: Q3 2024 in Review

Vazirani Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 25,000 shares — an estimated $1.02M sold.

Vazirani Asset Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $1.02M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Vazirani Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Vazirani Asset Management sold 25,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $1.02M.
  • Vazirani Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Vazirani Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $1.02M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Vazirani Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.